Research Topics

J Werner

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. Schoenberg M, Hao J, Bucher J, Miksch R, Anger H, Mayer B, et al. Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients. Cancers (Basel). 2018;10: pubmed publisher
    ..Our novel perivascular infiltration scoring (PVIS) can independently predict both DFS and OS in resected HCC patients. ..
  2. Habermehl D, Brecht I, Bergmann F, Rieken S, Werner J, Büchler M, et al. Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. World J Surg Oncol. 2015;13:149 pubmed publisher
    ..Patients undergoing additive CRT have a rather good OS and PFS compared to historical control patient groups. ..
  3. Weniger M, D Haese J, Kunz W, Pratschke S, Guba M, Werner J, et al. En-bloc resection of a giant retroperitoneal lipoma: a case report and review of the literature. BMC Res Notes. 2015;8:75 pubmed publisher
    ..Moreover, abdominal symptoms, i.e. pain, obstipation and dysphagia may occur due to mechanical displacement. Therefore, surgical exploration with complete oncological resection is the therapy of choice if malignity cannot be ruled out. ..
  4. D Haese J, Werner J. [Resectability of pancreatic cancer: New criteria]. Radiologe. 2016;56:318-24 pubmed publisher
    ..Pancreatic resections can nowadays be more radically performed due to advances in surgical techniques. This has led to a change in the criteria for resectability, especially concerning venous tumor infiltration. ..
  5. Renz B, D Haese J, Werner J, Westphalen C, Ilmer M. Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs). Med Sci (Basel). 2017;5: pubmed publisher
    ..As such, recycling drugs could present an intriguing and fast-track method with new therapeutic paradigms in anti-cancer and anti-CSC treatments. Here, we aim to summarize important aspects and novel findings of this emerging field. ..
  6. Kleespies A, Mikhailov M, Khalil P, Pratschke S, Khandoga A, Stangl M, et al. Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation. BMC Complement Altern Med. 2017;17:440 pubmed publisher
    ..Thus, concerns of patients awaiting LDKT regarding the ideal time of surgery can be allayed, and surgery may be scheduled independently of the lunar phases. ..